Bristol-Myers Squibb

Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Fierce Pharma
drug pricing
China
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Flag link:
Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial
Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial
BioSpace
Bristol-Myers Squibb
BMS-986165
psoriasis
clinical trials
Flag link:
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
CP Wire
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
FDA
Flag link:
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
Flag link:
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Yahoo/Zacks.com
Bristol-Myers Squibb
Empliciti
Celgene
Pomalyst
Multiple Myeloma
Flag link:
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
New York Times, NY
melanoma
Opdivo
clinical trials
Bristol-Myers Squibb
Flag link:
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Endpoints
Bristol-Myers Squibb
China
Opdivo
drug pricing
Flag link:
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Xconomy
FDA
Opdivo
Bristol-Myers Squibb
small cell lung cancer
Flag link:
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
CP Wire
Clovis Oncology
clinical trials
Bristol-Myers Squibb
Opdivo
ovarian cancer
Flag link:
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Stat
Abilify
compulsive behavior
Bristol-Myers Squibb
Otsuka
Flag link:
Opdivo Approved in Europe for Additional Use in Melanoma Patients
Opdivo Approved in Europe for Additional Use in Melanoma Patients
CP Wire
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Europe
Flag link:
Opdivo Approved in Europe for Additional Use in Melanoma Patients
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Flag link:
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
Fierce Pharma
Pfizer
Bristol-Myers Squibb
JNJ
Eliquis
Xarelto
Warfarin
bloodthinners
Flag link:
After an epic battle of blockbusters, Merck leapfrogs Bristol-Myers to take the lead on PD-1/L1 market
After an epic battle of blockbusters, Merck leapfrogs Bristol-Myers to take the lead on PD-1/L1 market
Endpoints
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
anti-PD-L1
Flag link:
Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook
Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook
Yahoo/Zacks.com
earnings
Bristol-Myers Squibb
Flag link:
Bristol-Myers Squibb signs new development agreement for autoimmune disorders treatments
Bristol-Myers Squibb signs new development agreement for autoimmune disorders treatments
GoinPharma
autoimmune disease
Bristol-Myers Squibb
Flag link:
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
CP Wire
Bristol-Myers Squibb
Gritstone Oncology
Opdivo
Yervoy
GRANITE-001
cancer
Flag link:
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike
Xconomy
IFM Therapeutics
Bristol-Myers Squibb
IFM Tre
Flag link:
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
Bristol-Myers Squibb
Gritstone Oncology
Opdivo
Flag link:
Opdivo Gains New Approval in Combination with Yervoy
Opdivo Gains New Approval in Combination with Yervoy
CP Wire
Opdivo
Yervoy
Bristol-Myers Squibb
metastatic colorectal cancer
Flag link:

Pages